---
title: "GSK Set for $500 Million Payment From mRNA Lawsuit Settlement"
date: 2025-08-08T07:27:07+08:00
categories: ["finance"]
tags: ["NYS:PFE", "NMS:BNTX", "NAS:CVAC", "LSE:GSK"]
summary: "CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer Inc. and BioNTech SE in the US, which will see CureVac’s former collaborator GSK Plc receive as much as $500 million"
source_url: "https://www.bloomberg.com/news/articles/2025-08-08/gsk-set-for-500-million-payment-from-mrna-lawsuit-settlement"
---

CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer Inc. and BioNTech SE in the US, which will see CureVac’s former collaborator GSK Plc receive as much as $500 million and 1% of royalties from future vaccine sales.

---

*来源: [原文链接](https://www.bloomberg.com/news/articles/2025-08-08/gsk-set-for-500-million-payment-from-mrna-lawsuit-settlement)*
